Sotrovimab medication can be used to treat adults and children above the age of 12 who meet certain criteria and are at risk of severe cases of COVID-19
Abu Dhabi first in the world to receive coronavirus medication Sotrovimab
Ministry of Health and Prevention says Sotrovimab offers the prospect of reducing hospitalisation for more than 24 hours and fatalities by as much as 85% when administered to patients as an early treatment for COVID-19.
Thursday 17/06/2021
Sotrovimab medication can be used to treat adults and children above the age of 12 who meet certain criteria and are at risk of severe cases of COVID-19
CAIRO - UAE's Abu Dhabi received its first shipment of the coronavirus Sotrovimab medication, becoming the first city globally to receive it, the media office said on a tweet on Wednesday.
The Ministry of Health and Prevention approved the emergency use of Sotrovimab in May, saying it "offers the prospect of reducing hospitalisation for more than 24 hours and fatalities by as much as 85% when administered to patients as an early treatment for COVID-19," the state news agency reported.
The medication can be used to treat adults and children above the age of 12 who meet certain criteria and are at risk of severe cases of COVID-19, under protocols developed by the National Scientific Committee.
After receiving positive scientific opinion from the European Medicines Agency, GlaxoSmithKline applied to have Sotrovimab approved for emergency use by the US Food and Drug Administration and the UAE Ministry of Health and Prevention.